Literature DB >> 26893526

Tree-based methods for individualized treatment regimes.

E B Laber1, Y Q Zhao2.   

Abstract

Individualized treatment rules recommend treatments on the basis of individual patient characteristics. A high-quality treatment rule can produce better patient outcomes, lower costs and less treatment burden. If a treatment rule learned from data is to be used to inform clinical practice or provide scientific insight, it is crucial that it be interpretable; clinicians may be unwilling to implement models they do not understand, and black-box models may not be useful for guiding future research. The canonical example of an interpretable prediction model is a decision tree. We propose a method for estimating an optimal individualized treatment rule within the class of rules that are representable as decision trees. The class of rules we consider is interpretable but expressive. A novel feature of this problem is that the learning task is unsupervised, as the optimal treatment for each patient is unknown and must be estimated. The proposed method applies to both categorical and continuous treatments and produces favourable marginal mean outcomes in simulation experiments. We illustrate it using data from a study of major depressive disorder.

Entities:  

Keywords:  Continuous treatment; Exploratory analysis; Personalized medicine; Treatment regime; Tree-based method

Year:  2015        PMID: 26893526      PMCID: PMC4755313          DOI: 10.1093/biomet/asv028

Source DB:  PubMed          Journal:  Biometrika        ISSN: 0006-3444            Impact factor:   2.445


  21 in total

1.  The path to personalized medicine.

Authors:  Margaret A Hamburg; Francis S Collins
Journal:  N Engl J Med       Date:  2010-06-15       Impact factor: 91.245

Review 2.  Biomarkers in cancer staging, prognosis and treatment selection.

Authors:  Joseph A Ludwig; John N Weinstein
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

3.  The art and science of personalized medicine.

Authors:  M Piquette-Miller; D M Grant
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

4.  Subgroup identification from randomized clinical trial data.

Authors:  Jared C Foster; Jeremy M G Taylor; Stephen J Ruberg
Journal:  Stat Med       Date:  2011-08-04       Impact factor: 2.373

5.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

6.  Q- and A-learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Authors:  Phillip J Schulte; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Stat Sci       Date:  2014-11       Impact factor: 2.901

7.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

8.  Estimating Optimal Treatment Regimes from a Classification Perspective.

Authors:  Baqun Zhang; Anastasios A Tsiatis; Marie Davidian; Min Zhang; Eric Laber
Journal:  Stat       Date:  2012-01-01

9.  Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations.

Authors:  Jeffrey Cummings; Murat Emre; Dag Aarsland; Sibel Tekin; Nalina Dronamraju; Roger Lane
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 10.  American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

Authors:  Carmen J Allegra; J Milburn Jessup; Mark R Somerfield; Stanley R Hamilton; Elizabeth H Hammond; Daniel F Hayes; Pamela K McAllister; Roscoe F Morton; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2009-02-02       Impact factor: 44.544

View more
  38 in total

1.  Random forests of interaction trees for estimating individualized treatment effects in randomized trials.

Authors:  Xiaogang Su; Annette T Peña; Lei Liu; Richard A Levine
Journal:  Stat Med       Date:  2018-04-29       Impact factor: 2.373

2.  Tree based weighted learning for estimating individualized treatment rules with censored data.

Authors:  Yifan Cui; Ruoqing Zhu; Michael Kosorok
Journal:  Electron J Stat       Date:  2017-10-18       Impact factor: 1.125

3.  Assessing the incremental value of new biomarkers based on OR rules.

Authors:  Lu Wang; Alexander R Luedtke; Ying Huang
Journal:  Biostatistics       Date:  2020-07-01       Impact factor: 5.899

4.  Generated effect modifiers (GEM's) in randomized clinical trials.

Authors:  Eva Petkova; Thaddeus Tarpey; Zhe Su; R Todd Ogden
Journal:  Biostatistics       Date:  2016-07-27       Impact factor: 5.899

5.  Comparing cluster-level dynamic treatment regimens using sequential, multiple assignment, randomized trials: Regression estimation and sample size considerations.

Authors:  Timothy NeCamp; Amy Kilbourne; Daniel Almirall
Journal:  Stat Methods Med Res       Date:  2017-06-19       Impact factor: 3.021

6.  Flexible functional regression methods for estimating individualized treatment regimes.

Authors:  Adam Ciarleglio; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  Stat (Int Stat Inst)       Date:  2016-05-31

7.  Comment.

Authors:  Qian Guan; Eric B Laber; Brian J Reich
Journal:  J Am Stat Assoc       Date:  2016-10-18       Impact factor: 5.033

8.  Greedy outcome weighted tree learning of optimal personalized treatment rules.

Authors:  Ruoqing Zhu; Ying-Qi Zhao; Guanhua Chen; Shuangge Ma; Hongyu Zhao
Journal:  Biometrics       Date:  2016-10-04       Impact factor: 2.571

9.  Estimating individualized treatment regimes from crossover designs.

Authors:  Crystal T Nguyen; Daniel J Luckett; Anna R Kahkoska; Grace E Shearrer; Donna Spruijt-Metz; Jaimie N Davis; Michael R Kosorok
Journal:  Biometrics       Date:  2019-12-19       Impact factor: 2.571

10.  Learning Personalized Treatment Rules from Electronic Health Records Using Topic Modeling Feature Extraction.

Authors:  Peng Wu; Tianchen Xu; Yuanjia Wang
Journal:  Proc Int Conf Data Sci Adv Anal       Date:  2020-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.